Despite the severe hereditary burden for BRCA1/BRCA2 mutation carriers to develop ovarian cancer, histological examination of tissue from prophylactic salpingo-oophorectomy failed to find any notable differences in the incidence of premalignant lesions of the ovarian epithelium compared to controls. The gene discussed is BRCA2; the disease is ovarian cancer.